Metagenomi, Inc. Common Stock (MGX)
USD 1.39
(10.32%)
USD 1.39
(10.32%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -92.37 Million USD | 44.31% |
| 2022 | -165.87 Million USD | -1822.07% |
| 2021 | 9.63 Million USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | -13.24 Million USD | 75.7% |
| 2024 Q1 | -54.49 Million USD | 41.01% |
| 2023 Q4 | -92.37 Million USD | -72.05% |
| 2023 Q3 | -53.69 Million USD | -1585.19% |
| 2023 FY | -92.37 Million USD | 44.31% |
| 2023 Q2 | -3.18 Million USD | -100.88% |
| 2023 Q1 | 362.13 Million USD | 318.32% |
| 2022 FY | -165.87 Million USD | -1822.07% |
| 2022 Q4 | -165.87 Million USD | 0.0% |
| 2021 FY | 9.63 Million USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| AbCellera Biologics Inc. | -55.94 Million USD | -65.13% |
| Alkermes plc | -166.73 Million USD | 44.6% |
| Agenus Inc. | 274.13 Million USD | 133.696% |
| Alnylam Pharmaceuticals, Inc. | 1.86 Billion USD | 104.94% |
| Aptorum Group Limited | 1.35 Million USD | 6906.991% |
| Ardelyx, Inc. | 34.51 Million USD | 367.658% |
| Arrowhead Pharmaceuticals, Inc. | 4.28 Million USD | 2258.271% |
| Bicycle Therapeutics plc | -481.46 Million USD | 80.814% |
| BioXcel Therapeutics, Inc. | 36.16 Million USD | 355.438% |
| ChromaDex Corporation | -24.04 Million USD | -284.123% |
| Chimerix, Inc. | -25.51 Million USD | -262.01% |
| Corbus Pharmaceuticals Holdings, Inc. | 6.96 Million USD | 1425.674% |
| Caribou Biosciences, Inc. | -23.67 Million USD | -290.142% |
| CRISPR Therapeutics AG | -150.84 Million USD | 38.762% |
| Precision BioSciences, Inc. | -85.41 Million USD | -8.154% |
| Dyadic International, Inc. | -6.37 Million USD | -1348.3% |
| Eton Pharmaceuticals, Inc. | -15.93 Million USD | -479.765% |
| Fortress Biotech, Inc. | 7.66 Million USD | 1305.14% |
| Lantern Pharma Inc. | -21.7 Million USD | -325.622% |
| HOOKIPA Pharma Inc. | -110.53 Million USD | 16.432% |
| Inhibikase Therapeutics, Inc. | -8.54 Million USD | -981.261% |
| Incyte Corporation | -3.17 Billion USD | 97.091% |
| IO Biotech, Inc. | -140.69 Million USD | 34.346% |
| Jaguar Health, Inc. | 29.39 Million USD | 414.293% |
| Novavax, Inc. | -298.29 Million USD | 69.033% |
| Janux Therapeutics, Inc. | 5.33 Million USD | 1830.823% |
| Opthea Limited | 28.15 Million USD | 428.062% |
| Ligand Pharmaceuticals Incorporated | -16.78 Million USD | -450.205% |
| ContextLogic Inc. | -232 Million USD | 60.184% |
| MiMedx Group, Inc. | -33.9 Million USD | -172.482% |
| Pyxis Oncology, Inc. | 10.19 Million USD | 1006.072% |
| TransCode Therapeutics, Inc. | -2.31 Million USD | -3886.747% |
| NextCure, Inc. | -6.47 Million USD | -1326.185% |
| Ocuphire Pharma, Inc. | -50.5 Million USD | -82.915% |
| Oncternal Therapeutics, Inc. | -6.37 Million USD | -1348.095% |
| Outlook Therapeutics, Inc. | 12.16 Million USD | 859.451% |
| Vaxcyte, Inc. | -368.22 Million USD | 74.914% |
| PDS Biotechnology Corporation | -32.7 Million USD | -182.412% |
| Madrigal Pharmaceuticals, Inc. | 17.27 Million USD | 634.634% |
| Pharming Group N.V. | 109.8 Million USD | 184.126% |
| Pieris Pharmaceuticals, Inc. | -17.39 Million USD | -431.007% |
| Avidity Biosciences, Inc. | -175.23 Million USD | 47.284% |
| Reviva Pharmaceuticals Holdings, Inc. | -18.51 Million USD | -398.784% |
| Reviva Pharmaceuticals Holdings, Inc. | -18.51 Million USD | -398.784% |
| Sangamo Therapeutics, Inc. | -7.1 Million USD | -1201.042% |
| Sol-Gel Technologies Ltd. | -5.86 Million USD | -1476.348% |
| Acelyrin, Inc. | -216.9 Million USD | 57.412% |
| Salarius Pharmaceuticals, Inc. | -5.61 Million USD | -1546.517% |
| SELLAS Life Sciences Group, Inc. | -1.72 Million USD | -5258.121% |
| Summit Therapeutics Inc. | 34.67 Million USD | 366.407% |
| Sensei Biotherapeutics, Inc. | -6.8 Million USD | -1257.842% |
| Senti Biosciences, Inc. | 1.74 Million USD | 5408.851% |
| Stoke Therapeutics, Inc. | -184.6 Million USD | 49.962% |
| Syros Pharmaceuticals, Inc. | -77.45 Million USD | -19.268% |
| Alaunos Therapeutics, Inc. | -6.06 Million USD | -1423.821% |
| Telomir Pharmaceuticals, Inc. Common Stock | 99.76 Thousand USD | 92687.878% |
| Entrada Therapeutics, Inc. | 628 Thousand USD | 14809.236% |
| VistaGen Therapeutics, Inc. | -117.04 Million USD | 21.079% |
| Wave Life Sciences Ltd. | -168.23 Million USD | 45.092% |
| Sorrento Therapeutics, Inc. | 110.87 Million USD | 183.317% |
| TRACON Pharmaceuticals, Inc. | -7.59 Million USD | -1116.087% |
| Barinthus Biotherapeutics plc | -129.11 Million USD | 28.455% |
| Psyence Biomedical Ltd. | 6.89 Million USD | 1439.803% |
| Phathom Pharmaceuticals, Inc. | -242.36 Million USD | 61.886% |
| Immix Biopharma, Inc. | -17.5 Million USD | -427.556% |
| Keros Therapeutics, Inc. | -316.7 Million USD | 70.833% |
| MEI Pharma, Inc. | -3.7 Million USD | -2393.225% |
| Windtree Therapeutics, Inc. | 12.51 Million USD | 838.342% |
| Xeris Biopharma Holdings, Inc. | 161.74 Million USD | 157.112% |
| Rigel Pharmaceuticals, Inc. | 27.79 Million USD | 432.364% |
| Fortress Biotech, Inc. | 7.66 Million USD | 1305.14% |
| Precigen, Inc. | -481 Thousand USD | -19104.574% |
| Clearside Biomedical, Inc. | 14.08 Million USD | 756.019% |
| AlloVir, Inc. | -62.69 Million USD | -47.346% |
| C4 Therapeutics, Inc. | -55.61 Million USD | -66.098% |
| Fate Therapeutics, Inc. | 61.66 Million USD | 249.797% |
| ImmuCell Corporation | 10.99 Million USD | 940.485% |
| IDEAYA Biosciences, Inc. | -154.14 Million USD | 40.074% |
| Onconetix, Inc. | 5.33 Million USD | 1832.629% |
| PureTech Health plc | -167.19 Million USD | 44.751% |
| VYNE Therapeutics Inc. | -30.46 Million USD | -203.263% |
| Elevation Oncology, Inc. | -19.11 Million USD | -383.178% |
| Kintara Therapeutics, Inc. | -4.9 Million USD | -1781.727% |
| Seer, Inc. | -4.24 Million USD | -2078.632% |
| Verrica Pharmaceuticals Inc. | -24.03 Million USD | -284.299% |
| Innoviva, Inc. | 255.56 Million USD | 136.145% |
| Aadi Bioscience, Inc. | -55.86 Million USD | -65.355% |
| ESSA Pharma Inc. | -33.62 Million USD | -174.746% |
| GlycoMimetics, Inc. | -40.98 Million USD | -125.388% |
| GT Biopharma, Inc. | -1.02 Million USD | -8947.405% |
| Inhibrx Biosciences, Inc. | -67.78 Million USD | -36.279% |
| Akebia Therapeutics, Inc. | 61.25 Million USD | 250.797% |
| Catalyst Pharmaceuticals, Inc. | -134.07 Million USD | 31.105% |
| Longboard Pharmaceuticals, Inc. | -13.85 Million USD | -566.671% |
| Orchestra BioMed Holdings, Inc. | -28.87 Million USD | -219.943% |
| Alzamend Neuro, Inc. | -75.33 Thousand USD | -122519.269% |
| Rocket Pharmaceuticals, Inc. | -30.86 Million USD | -199.313% |
| Aptose Biosciences Inc. | -8.19 Million USD | -1027.219% |
| ZyVersa Therapeutics, Inc. | -3.12 Million USD | -2852.172% |
| Soligenix, Inc. | -4.95 Million USD | -1765.54% |
| Century Therapeutics, Inc. | 847 Thousand USD | 11006.021% |
| Kura Oncology, Inc. | -20.11 Million USD | -359.161% |
| TScan Therapeutics, Inc. | -40.92 Million USD | -125.71% |
| Intensity Therapeutics, Inc. | -8.39 Million USD | -999.952% |
| Ocean Biomedical, Inc. | 1.82 Million USD | 5170.772% |
| CytomX Therapeutics, Inc. | -3.19 Million USD | -2789.396% |
| Autolus Therapeutics plc | -186.59 Million USD | 50.496% |
| Mineralys Therapeutics, Inc. | -49.3 Million USD | -87.356% |
| EyePoint Pharmaceuticals, Inc. | -275.79 Million USD | 66.506% |
| Eterna Therapeutics Inc. | 34.26 Million USD | 369.563% |
| Adaptive Biotechnologies Corporation | 164.36 Million USD | 156.2% |
| GRI Bio, Inc. | -1.79 Million USD | -5049.052% |
| Xenetic Biosciences, Inc. | -8.98 Million USD | -928.315% |
| Tenaya Therapeutics, Inc. | -33.25 Million USD | -177.758% |
| IGM Biosciences, Inc. | -72.6 Million USD | -27.226% |
| INmune Bio, Inc. | -25.41 Million USD | -263.52% |
| Heron Therapeutics, Inc. | 150.95 Million USD | 161.195% |
| SAB Biotherapeutics, Inc. | -50.65 Million USD | -82.345% |
| Pasithea Therapeutics Corp. | -16.24 Million USD | -468.477% |
| Entero Therapeutics, Inc. | -2.88 Million USD | -3101.954% |
| Milestone Pharmaceuticals Inc. | 38.01 Million USD | 342.994% |
| X4 Pharmaceuticals, Inc. | -41.18 Million USD | -124.29% |
| Atara Biotherapeutics, Inc. | 31.88 Million USD | 389.71% |
| Coherus BioSciences, Inc. | 377.95 Million USD | 124.441% |
| Verastem, Inc. | -37.27 Million USD | -147.798% |
| Abeona Therapeutics Inc. | -9.07 Million USD | -918.12% |
| Pliant Therapeutics, Inc. | -51.86 Million USD | -78.115% |
| Tonix Pharmaceuticals Holding Corp. | -15.13 Million USD | -510.334% |
| Histogen Inc. | -7.48 Million USD | -1133.792% |
| Aprea Therapeutics, Inc. | -21.6 Million USD | -327.522% |
| Surrozen, Inc. | -32.66 Million USD | -182.801% |
| Organovo Holdings, Inc. | -1.5 Million USD | -6029.662% |
| Lixte Biotechnology Holdings, Inc. | -4.2 Million USD | -2097.556% |
| Ovid Therapeutics Inc. | 18.96 Million USD | 587.199% |
| Panbela Therapeutics, Inc. | 2.61 Million USD | 3631.116% |
| CASI Pharmaceuticals, Inc. | 4.15 Million USD | 2322.666% |
| Cadrenal Therapeutics, Inc. Common Stock | -8.38 Million USD | -1002.164% |
| Centessa Pharmaceuticals plc | -43.44 Million USD | -112.638% |
| Hepion Pharmaceuticals, Inc. | -14.57 Million USD | -533.703% |
| Arcturus Therapeutics Holdings Inc. | -316.78 Million USD | 70.841% |
| BioRestorative Therapies, Inc. | -722.06 Thousand USD | -12693.12% |
| Apollomics, Inc. | -27.39 Million USD | -237.193% |
| Amarin Corporation plc | -191.04 Million USD | 51.647% |
| Mesoblast Limited | 55.96 Million USD | 265.063% |
| Turnstone Biologics Corp. | -14.58 Million USD | -533.393% |
| Kymera Therapeutics, Inc. | -25.29 Million USD | -265.23% |
| Synaptogenix, Inc. | -28.66 Million USD | -222.293% |
| Tiziana Life Sciences Ltd | -936 Thousand USD | -9769.017% |
| Aurinia Pharmaceuticals Inc. | 48.73 Million USD | 289.555% |
| BriaCell Therapeutics Corp. | -862.08 Thousand USD | -10615.135% |
| Monopar Therapeutics Inc. | -7.26 Million USD | -1171.304% |
| Exelixis, Inc. | -73.05 Million USD | -26.453% |
| Better Therapeutics, Inc. | -860 Thousand USD | -10641.163% |
| Nurix Therapeutics, Inc. | -24.01 Million USD | -284.683% |
| Apellis Pharmaceuticals, Inc. | -241.37 Million USD | 61.729% |
| NLS Pharmaceutics AG | 736.06 Thousand USD | 12649.69% |
| Dermata Therapeutics, Inc. | -7.43 Million USD | -1141.897% |
| Aridis Pharmaceuticals, Inc. | 1.25 Million USD | 7466.348% |
| Gritstone bio, Inc. | 39.49 Million USD | 333.917% |
| Jasper Therapeutics, Inc. | -84.1 Million USD | -9.837% |
| TNF Pharmaceuticals, Inc. | -2.63 Million USD | -3409.464% |
| Avid Bioservices, Inc. | 169.72 Million USD | 154.425% |
| Insmed Incorporated | 721.62 Million USD | 112.801% |
| Virpax Pharmaceuticals, Inc. | -9.14 Million USD | -910.489% |
| MediWound Ltd. | -5.32 Million USD | -1635.701% |
| OmniAb, Inc. | 9.2 Million USD | 1103.738% |
| Alector, Inc. | -35.63 Million USD | -159.208% |
| Seres Therapeutics, Inc. | 85.97 Million USD | 207.448% |
| Checkpoint Therapeutics, Inc. | -4.92 Million USD | -1774.472% |
| Viracta Therapeutics, Inc. | 13.23 Million USD | 797.742% |
| Zai Lab Limited | -775 Million USD | 88.081% |
| Revance Therapeutics, Inc. | 340.55 Million USD | 127.125% |
| Aura Biosciences, Inc. | -21.52 Million USD | -329.148% |
| Lyell Immunopharma, Inc. | -82.48 Million USD | -11.996% |
| Immunic, Inc. | -45.34 Million USD | -103.736% |
| Tarsus Pharmaceuticals, Inc. | -193.21 Million USD | 52.191% |
| Veracyte, Inc. | -203.82 Million USD | 54.68% |
| InMed Pharmaceuticals Inc. | 638.29 Million USD | 114.472% |
| FibroGen, Inc. | 56.76 Million USD | 262.725% |
| SeaStar Medical Holding Corporation | 8.9 Million USD | 1137.327% |
| Adial Pharmaceuticals, Inc. | -2.82 Million USD | -3167.468% |
| Sonnet BioTherapeutics Holdings, Inc. | -2.07 Million USD | -4361.762% |
| Jazz Pharmaceuticals plc | 4.59 Billion USD | 102.012% |
| Cyclacel Pharmaceuticals, Inc. | -3.34 Million USD | -2664.861% |
| Amylyx Pharmaceuticals, Inc. | -165.96 Million USD | 44.341% |
| TG Therapeutics, Inc. | 17.86 Million USD | 617.154% |
| Galecto, Inc. | -21.21 Million USD | -335.398% |
| Calithera Biosciences, Inc. | -23.78 Million USD | -288.371% |
| Fortrea Holdings Inc. | 1.56 Billion USD | 105.886% |
| KalVista Pharmaceuticals, Inc. | -24.47 Million USD | -277.468% |
| Aptevo Therapeutics Inc. | -11.5 Million USD | -702.764% |
| XBiotech Inc. | -200.02 Million USD | 53.818% |
| Jasper Therapeutics, Inc. | -84.1 Million USD | -9.837% |
| Lyra Therapeutics, Inc. | 4.52 Million USD | 2140.062% |
| Foghorn Therapeutics Inc. | -35.26 Million USD | -161.957% |
| Y-mAbs Therapeutics, Inc. | -77.21 Million USD | -19.628% |
| Theravance Biopharma, Inc. | 5.69 Million USD | 1723.159% |
| Ultragenyx Pharmaceutical Inc. | -170.41 Million USD | 45.795% |
| Vaxxinity, Inc. | 10.13 Million USD | 1011.705% |
| BioCryst Pharmaceuticals, Inc. | 736.26 Million USD | 112.546% |
| Gain Therapeutics, Inc. | -10.76 Million USD | -757.892% |
| Cartesian Therapeutics, Inc. | -65.95 Million USD | -40.054% |
| NexImmune, Inc. | -3.13 Million USD | -2847.815% |
| Creative Medical Technology Holdings, Inc. | -3.45 Million USD | -2575.434% |
| Marker Therapeutics, Inc. | -15.11 Million USD | -511.285% |
| Regeneron Pharmaceuticals, Inc. | -27.1 Million USD | -240.863% |
| Chemomab Therapeutics Ltd. | -8.97 Million USD | -929.116% |
| Scopus BioPharma Inc. | -124.57 Thousand USD | -74051.314% |
| RAPT Therapeutics, Inc. | -40.57 Million USD | -127.679% |
| Ainos, Inc. | 4.07 Million USD | 2365.219% |
| Pluri Inc. | 22.82 Million USD | 504.634% |
| Prothena Corporation plc | -608.34 Million USD | 84.816% |
| Adaptimmune Therapeutics plc | -118.75 Million USD | 22.215% |
| Celularity Inc. | 65.19 Million USD | 241.7% |
| Rallybio Corporation | -24.1 Million USD | -283.263% |
| Cue Biopharma, Inc. | -33.81 Million USD | -173.142% |
| MeiraGTx Holdings plc | -40.3 Million USD | -129.205% |
| Omeros Corporation | 331.17 Million USD | 127.893% |
| Humacyte, Inc. | -22.48 Million USD | -310.807% |
| Immunocore Holdings plc | -358.59 Million USD | 74.24% |
| Cocrystal Pharma, Inc. | -24.57 Million USD | -275.886% |
| Cidara Therapeutics, Inc. | -30.9 Million USD | -198.935% |
| Blueprint Medicines Corporation | 702.83 Million USD | 113.143% |
| CalciMedica, Inc. | -5.53 Million USD | -1570.416% |
| Cabaletta Bio, Inc. | -188.22 Million USD | 50.922% |
| Marinus Pharmaceuticals, Inc. | -10.21 Million USD | -804.386% |
| Scholar Rock Holding Corporation | -40.03 Million USD | -130.722% |
| Sana Biotechnology, Inc. | -33.25 Million USD | -177.791% |
| Pulmatrix, Inc. | -10.41 Million USD | -786.762% |
| Elicio Therapeutics, Inc. | -5.97 Million USD | -1445.491% |
| Vigil Neuroscience, Inc. | -38.14 Million USD | -142.184% |
| Intellia Therapeutics, Inc. | -111.4 Million USD | 17.08% |
| Adlai Nortye Ltd. American Depositary Shares | -59.94 Million USD | -54.1% |
| Cytokinetics, Incorporated | 642.37 Million USD | 114.38% |
| Eloxx Pharmaceuticals, Inc. | -5.82 Million USD | -1486.364% |
| Nutriband Inc. | -251.65 Thousand USD | -36606.311% |
| Protara Therapeutics, Inc. | -34.11 Million USD | -170.741% |
| Vor Biopharma Inc. | 4.3 Million USD | 2248.233% |
| Roivant Sciences Ltd. | -6.03 Billion USD | 98.47% |
| Evogene Ltd. | -19.63 Million USD | -370.48% |
| ProKidney Corp. | -56.23 Million USD | -64.261% |
| Applied Therapeutics, Inc. | -48.67 Million USD | -89.789% |
| Hoth Therapeutics, Inc. | -9.23 Million USD | -900.023% |
| BridgeBio Pharma, Inc. | 1.36 Billion USD | 106.773% |
| CorMedix Inc. | -43.05 Million USD | -114.561% |
| BioLineRx Ltd. | 7.33 Million USD | 1359.188% |
| Tango Therapeutics, Inc. | -27.46 Million USD | -236.334% |
| Galectin Therapeutics Inc. | 46.14 Million USD | 300.173% |
| Atai Life Sciences N.V. | -28.55 Million USD | -223.461% |
| Renovaro Biosciences Inc. | 2.23 Million USD | 4241.349% |
| Aerovate Therapeutics, Inc. | -22.81 Million USD | -304.865% |
| Zentalis Pharmaceuticals, Inc. | 17.73 Million USD | 620.857% |
| Sagimet Biosciences Inc. | -75.07 Million USD | -23.044% |
| MediciNova, Inc. | -50.78 Million USD | -81.898% |
| Praxis Precision Medicines, Inc. | -78.8 Million USD | -17.218% |
| Cardio Diagnostics Holdings, Inc. | -22.49 Thousand USD | -410542.365% |
| GeoVax Labs, Inc. | -6.45 Million USD | -1331.58% |
| Axsome Therapeutics, Inc. | -199.82 Million USD | 53.772% |
| Biomea Fusion, Inc. | -166.57 Million USD | 44.543% |
| PTC Therapeutics, Inc. | -178.97 Million USD | 48.387% |
| Mereo BioPharma Group plc | -51.46 Million USD | -79.475% |
| Cullinan Oncology, Inc. | -94.84 Million USD | 2.604% |
| Syndax Pharmaceuticals, Inc. | -293.75 Million USD | 68.554% |
| Absci Corporation | -72.59 Million USD | -27.24% |
| NRx Pharmaceuticals, Inc. | 4.56 Million USD | 2123.084% |
| 4D Molecular Therapeutics, Inc. | -234.43 Million USD | 60.598% |
| Dyne Therapeutics, Inc. | -94.21 Million USD | 1.95% |
| Kiniksa Pharmaceuticals, Ltd. | -95.69 Million USD | 3.471% |
| Ventyx Biosciences, Inc. | -39.07 Million USD | -136.414% |
| Allakos Inc. | -24.97 Million USD | -269.866% |
| Imunon, Inc. | -4.21 Million USD | -2092.151% |
| Fulcrum Therapeutics, Inc. | -14.74 Million USD | -526.604% |
| Corcept Therapeutics Incorporated | -135.4 Million USD | 31.777% |
| BioAtla, Inc. | -109.01 Million USD | 15.262% |
| NLS Pharmaceutics AG | 736.06 Thousand USD | 12649.69% |
| Bio-Path Holdings, Inc. | -939 Thousand USD | -9737.487% |
| Allogene Therapeutics, Inc. | 11.96 Million USD | 871.971% |
| Larimar Therapeutics, Inc. | -21.2 Million USD | -335.665% |
| XOMA Corporation | -29 Million USD | -218.531% |
| Kezar Life Sciences, Inc. | -16.56 Million USD | -457.814% |
| Cara Therapeutics, Inc. | -9.01 Million USD | -924.556% |
| aTyr Pharma, Inc. | -7.44 Million USD | -1140.086% |
| Aligos Therapeutics, Inc. | -124.63 Million USD | 25.885% |
| Akero Therapeutics, Inc. | -208.16 Million USD | 55.624% |
| Viridian Therapeutics, Inc. | -81.77 Million USD | -12.956% |
| Eliem Therapeutics, Inc. | -92.76 Million USD | 0.419% |
| EyeGate Pharmaceuticals, Inc. | -859.18 Thousand USD | -10651.364% |
| Akari Therapeutics, Plc | -3.84 Million USD | -2302.445% |
| Tevogen Bio Holdings Inc. | 1.62 Million USD | 5791.945% |
| Halozyme Therapeutics, Inc. | 1.38 Billion USD | 106.69% |
| Lexaria Bioscience Corp. | -1.18 Million USD | -7674.706% |
| UroGen Pharma Ltd. | 4.39 Million USD | 2203.712% |
| Sutro Biopharma, Inc. | 113.48 Million USD | 181.4% |
| ZIVO Bioscience, Inc. | 71.96 Thousand USD | 128464.97% |
| Orgenesis Inc. | 21.78 Million USD | 524.045% |
| Entera Bio Ltd. | -10.62 Million USD | -769.075% |
| GH Research PLC | -78.07 Million USD | -18.311% |
| Lisata Therapeutics, Inc. | -22.28 Million USD | -314.456% |
| Reneo Pharmaceuticals, Inc. | -26.65 Million USD | -246.502% |
| Xencor, Inc. | 29.64 Million USD | 411.611% |
| 60 Degrees Pharmaceuticals, Inc. | -1.96 Million USD | -4589.483% |
| Replimune Group, Inc. | 1.41 Million USD | 6642.068% |
| Coeptis Therapeutics Holdings, Inc. | -244.9 Thousand USD | -37617.837% |
| Vanda Pharmaceuticals Inc. | -126.41 Million USD | 26.929% |
| Lexaria Bioscience Corp. | -1.18 Million USD | -7674.706% |
| Portage Biotech Inc. | -4.98 Million USD | -1754.527% |
| Cardio Diagnostics Holdings, Inc. | -22.49 Thousand USD | -410542.365% |
| Olema Pharmaceuticals, Inc. | -66.12 Million USD | -39.702% |
| OncoCyte Corporation | -6.56 Million USD | -1307.497% |
| Qualigen Therapeutics, Inc. | 897.41 Thousand USD | 10393.365% |
| Processa Pharmaceuticals, Inc. | -4.55 Million USD | -1927.683% |
| Purple Biotech Ltd. | -14.13 Million USD | -553.374% |
| CollPlant Biotechnologies Ltd. | -23.75 Million USD | -288.845% |
| scPharmaceuticals Inc. | -6.54 Million USD | -1311.367% |
| ProMIS Neurosciences, Inc. | -16.69 Million USD | -453.397% |
| HilleVax, Inc. | -165.48 Million USD | 44.18% |
| NeuroSense Therapeutics Ltd. | -2.53 Million USD | -3539.638% |
| Tharimmune, Inc. | -10.93 Million USD | -744.728% |
| Genprex, Inc. | -6.73 Million USD | -1271.016% |
| Neumora Therapeutics, Inc. Common Stock | -368.8 Million USD | 74.953% |
| Atossa Therapeutics, Inc. | -88.46 Million USD | -4.425% |
| XTL Biopharmaceuticals Ltd. | -1.4 Million USD | -6493.433% |
| Virios Therapeutics, Inc. | -3.31 Million USD | -2684.911% |
| OKYO Pharma Limited | -826.84 Thousand USD | -11071.824% |
| Savara Inc. | 153 Thousand USD | 60475.163% |
| Curis, Inc. | -23.88 Million USD | -286.712% |
| Daré Bioscience, Inc. | -5.15 Million USD | -1690.919% |
| Carmell Therapeutics Corporation | -776.01 Thousand USD | -11803.682% |
| Titan Pharmaceuticals, Inc. | -6.2 Million USD | -1387.983% |
| Achieve Life Sciences, Inc. | 1.18 Million USD | 7895.274% |
| BeiGene, Ltd. | -2.25 Billion USD | 95.9% |
| Kiromic BioPharma, Inc. | 12.33 Million USD | 848.665% |
| Revolution Medicines, Inc. Warrant | -608.2 Million USD | 84.812% |
| Protagonist Therapeutics, Inc. | -185.58 Million USD | 50.226% |
| Erasca, Inc. | -37.21 Million USD | -148.21% |
| bluebird bio, Inc. | 108.57 Million USD | 185.082% |
| Protagenic Therapeutics, Inc. | -1.28 Million USD | -7072.49% |
| BioMarin Pharmaceutical Inc. | 378.74 Million USD | 124.389% |
| DBV Technologies S.A. | -126.98 Million USD | 27.257% |
| Protagenic Therapeutics, Inc. | -1.28 Million USD | -7072.49% |
| Moderna, Inc. | -2.9 Billion USD | 96.822% |
| Vincerx Pharma, Inc. | -10.35 Million USD | -792.33% |
| Fresh Tracks Therapeutics, Inc. | -10.86 Million USD | -749.963% |
| Molecular Templates, Inc. | 707 Thousand USD | 13165.629% |
| Acrivon Therapeutics, Inc. Common Stock | -31.37 Million USD | -194.457% |
| Travere Therapeutics, Inc. | 346.6 Million USD | 126.651% |
| Monte Rosa Therapeutics, Inc. | -82.06 Million USD | -12.566% |
| Spruce Biosciences, Inc. | -91.73 Million USD | -0.702% |
| Celldex Therapeutics, Inc. | -32.27 Million USD | -186.236% |
| Cogent Biosciences, Inc. | -34.37 Million USD | -168.717% |
| MacroGenics, Inc. | -66.98 Million USD | -37.903% |
| RenovoRx, Inc. | -1.17 Million USD | -7775.021% |
| Adicet Bio, Inc. | -138.78 Million USD | 33.442% |
| Prime Medicine, Inc. | -27.94 Million USD | -230.604% |
| Aditxt, Inc. | 18.12 Million USD | 609.765% |
| Adagene Inc. | -87.62 Million USD | -5.417% |
| Estrella Immunopharma, Inc. | -4.16 Million USD | -2117.635% |
| Quantum-Si incorporated | -118.55 Million USD | 22.085% |
| Maravai LifeSciences Holdings, Inc. | 36 Million USD | 356.559% |
| Acurx Pharmaceuticals, Inc. | -7.47 Million USD | -1135.907% |
| Voyager Therapeutics, Inc. | -48.5 Million USD | -90.427% |
| SciSparc Ltd. | -2.06 Million USD | -4373.317% |
| Vericel Corporation | 1.27 Million USD | 7333.673% |
| Revelation Biosciences, Inc. | -11.99 Million USD | -670.316% |
| Minerva Neurosciences, Inc. | 41 Million USD | 325.279% |
| Generation Bio Co. | 31.44 Million USD | 393.736% |
| Astria Therapeutics, Inc. | -175.36 Million USD | 47.324% |
| Black Diamond Therapeutics, Inc. | -30.92 Million USD | -198.723% |
| Arcutis Biotherapeutics, Inc. | 116.59 Million USD | 179.228% |
| Invivyd, Inc. | -198.47 Million USD | 53.458% |
| Relay Therapeutics, Inc. | -90.27 Million USD | -2.331% |
| Quoin Pharmaceuticals, Ltd. | -2.39 Million USD | -3752.628% |
| Spero Therapeutics, Inc. | -70.79 Million USD | -30.49% |
| Artelo Biosciences, Inc. | -6.82 Million USD | -1253.465% |
| 2seventy bio, Inc. | 181.71 Million USD | 150.835% |
| ADMA Biologics, Inc. | 90.06 Million USD | 202.563% |
| Clene Inc. | 3.34 Million USD | 2865.689% |
| Capricor Therapeutics, Inc. | -9.08 Million USD | -917.032% |
| Boundless Bio, Inc. Common Stock | -21.51 Million USD | -329.427% |
| GeoVax Labs, Inc. | -6.45 Million USD | -1331.58% |
| Recursion Pharmaceuticals, Inc. | -344.12 Million USD | 73.157% |
| Citius Pharmaceuticals, Inc. | -25.99 Million USD | -255.289% |
| Contineum Therapeutics, Inc. Class A Common Stock | 177.66 Million USD | 151.993% |
| Relmada Therapeutics, Inc. | -4.09 Million USD | -2157.668% |
| Finch Therapeutics Group, Inc. | 5 Million USD | 1946.741% |
| ALX Oncology Holdings Inc. | -5.2 Million USD | -1673.354% |
| Vir Biotechnology, Inc. | -130.3 Million USD | 29.109% |
| Evaxion Biotech A/S | 5.28 Million USD | 1847.243% |
| Ocular Therapeutix, Inc. | -112.56 Million USD | 17.939% |
| Verve Therapeutics, Inc. | -131.27 Million USD | 29.632% |
| Trevena, Inc. | 2.25 Million USD | 4190.965% |
| Surrozen, Inc. | -32.66 Million USD | -182.801% |
| Tyra Biosciences, Inc. | -51.51 Million USD | -79.332% |
| Cingulate Inc. | 3.08 Million USD | 3096.546% |
| Galmed Pharmaceuticals Ltd. | -2.93 Million USD | -3045.182% |
| Unity Biotechnology, Inc. | 7.18 Million USD | 1385.293% |
| Tenax Therapeutics, Inc. | -9.29 Million USD | -894.207% |
| Terns Pharmaceuticals, Inc. | -79.32 Million USD | -16.453% |
| ACADIA Pharmaceuticals Inc. | -131.45 Million USD | 29.728% |
| Connect Biopharma Holdings Limited | -105.54 Million USD | 12.477% |
| Clearmind Medicine Inc. | -3.94 Million USD | -2242.95% |
| Kronos Bio, Inc. | -36.05 Million USD | -156.21% |
| Bolt Biotherapeutics, Inc. | 9.4 Million USD | 1081.762% |
| CERo Therapeutics Holdings, Inc. | 1.45 Million USD | 6435.113% |
| Viking Therapeutics, Inc. | -54.25 Million USD | -70.256% |
| Statera Biopharma, Inc. | 14.41 Million USD | 740.756% |
| ImmunityBio, Inc. | 618.22 Million USD | 114.942% |
| Korro Bio, Inc. | -132.94 Million USD | 30.516% |
| Kineta, Inc. | -4.54 Million USD | -1934.222% |
| BioVie Inc. | -17.73 Million USD | -420.935% |
| Codexis, Inc. | -43.27 Million USD | -113.478% |
| Celularity Inc. | 65.19 Million USD | 241.7% |
| Crinetics Pharmaceuticals, Inc. | -3.16 Million USD | -2814.926% |
| Celcuity Inc. | 6.78 Million USD | 1461.744% |
| Virax Biolabs Group Limited | -3.36 Million USD | -2645.187% |
| Cibus, Inc. | -8.07 Million USD | -1043.526% |
| Eledon Pharmaceuticals, Inc. | -4.22 Million USD | -2084.299% |
| eFFECTOR Therapeutics, Inc. | 4.57 Million USD | 2121.313% |
| IN8bio, Inc. | -16.38 Million USD | -463.634% |
| Kodiak Sciences Inc. | -103.87 Million USD | 11.072% |
| Annexon, Inc. | -193.75 Million USD | 52.324% |
| Adverum Biotechnologies, Inc. | 36 Thousand USD | 256694.444% |
| Assembly Biosciences, Inc. | -17.49 Million USD | -427.882% |
| Avalo Therapeutics, Inc. | -3.51 Million USD | -2529.49% |
| Ionis Pharmaceuticals, Inc. | 1.05 Billion USD | 108.762% |
| Eyenovia, Inc. | 1.25 Million USD | 7438.83% |
| Puma Biotechnology, Inc. | 26.9 Million USD | 443.334% |
| Conduit Pharmaceuticals Inc. | -3.24 Million USD | -2748.412% |
| Xilio Therapeutics, Inc. | -33.24 Million USD | -177.842% |
| Arcellx, Inc. | -296.95 Million USD | 68.893% |
| Cardiff Oncology, Inc. | -19.5 Million USD | -373.567% |
| Enanta Pharmaceuticals, Inc. | -58.87 Million USD | -56.899% |
| Regulus Therapeutics Inc. | -20.72 Million USD | -345.67% |
| Moolec Science SA | 117.61 Thousand USD | 78638.634% |
| Acumen Pharmaceuticals, Inc. | -38.39 Million USD | -140.564% |
| Geron Corporation | 14.76 Million USD | 725.798% |
| LAVA Therapeutics N.V. | -37.91 Million USD | -143.615% |
| Royalty Pharma plc | 5.65 Billion USD | 101.633% |
| Atea Pharmaceuticals, Inc. | -141.42 Million USD | 34.682% |
| Greenwich LifeSciences, Inc. | -6.98 Million USD | -1221.625% |
| TFF Pharmaceuticals, Inc. | -5.36 Million USD | -1622.477% |
| Mersana Therapeutics, Inc. | -140.73 Million USD | 34.361% |
| Humacyte, Inc. | -22.48 Million USD | -310.807% |
| Structure Therapeutics Inc. | -124.33 Million USD | 25.708% |
| 89bio, Inc. | -289.05 Million USD | 68.043% |
| PMV Pharmaceuticals, Inc. | -25.24 Million USD | -265.954% |
| Avenue Therapeutics, Inc. | -1.78 Million USD | -5080.819% |
| Genelux Corporation | -6.89 Million USD | -1238.948% |
| Trevi Therapeutics, Inc. | -31.05 Million USD | -197.415% |
| Lexicon Pharmaceuticals, Inc. | 83.59 Million USD | 210.497% |
| Notable Labs, Ltd. | -9.77 Million USD | -844.906% |
| Liquidia Corporation | -80.17 Million USD | -15.214% |
| Mustang Bio, Inc. | -3.73 Million USD | -2372.537% |
| Immunovant, Inc. | -635.22 Million USD | 85.458% |
| Quantum-Si incorporated | -118.55 Million USD | 22.085% |
| Arbutus Biopharma Corporation | -17.56 Million USD | -425.928% |
| DiaMedica Therapeutics Inc. | -4.14 Million USD | -2129.64% |
| Vera Therapeutics, Inc. | 8.02 Million USD | 1250.791% |
| Acasti Pharma Inc. | -23 Million USD | -301.539% |
| MiNK Therapeutics, Inc. | -3.36 Million USD | -2643.324% |
| Pasithea Therapeutics Corp. | -16.24 Million USD | -468.477% |
| Xenon Pharmaceuticals Inc. | -137.74 Million USD | 32.936% |
| Elevai Labs, Inc. Common Stock | -3.11 Million USD | -2864.161% |
| NeuroBo Pharmaceuticals, Inc. | -22.23 Million USD | -315.5% |
| Tempest Therapeutics, Inc. | -18.56 Million USD | -397.464% |
| Soleno Therapeutics, Inc. | -169.27 Million USD | 45.431% |
| PepGen Inc. | -60.67 Million USD | -52.256% |
| Moleculin Biotech, Inc. | -22.97 Million USD | -302.046% |
| United Therapeutics Corporation | -507.7 Million USD | 81.805% |
| Nuvectis Pharma, Inc. | -19.12 Million USD | -382.976% |
| Solid Biosciences Inc. | -47.75 Million USD | -93.453% |
| BriaCell Therapeutics Corp. | -862.08 Thousand USD | -10615.135% |
| Immuneering Corporation | -54.94 Million USD | -68.127% |
| Lixte Biotechnology Holdings, Inc. | -4.2 Million USD | -2097.556% |
| Silo Pharma, Inc. | -3.52 Million USD | -2521.054% |
| Belite Bio, Inc | -87.27 Million USD | -5.847% |
| XOMA Corporation | -29 Million USD | -218.531% |
| ARS Pharmaceuticals, Inc. | -70.69 Million USD | -30.662% |
| Bionomics Limited | 227 Million USD | 140.692% |
| Apogee Therapeutics, Inc. | -116.28 Million USD | 20.56% |
| Alpha Tau Medical Ltd. | -2.53 Million USD | -3546.822% |
| uniQure N.V. | -102.95 Million USD | 10.274% |
| Cassava Sciences, Inc. | -121.13 Million USD | 23.744% |
| Estrella Immunopharma, Inc. | -4.16 Million USD | -2117.635% |
| Poseida Therapeutics, Inc. | 40.95 Million USD | 325.572% |
| Forte Biosciences, Inc. | -11.96 Million USD | -672.293% |
| Anebulo Pharmaceuticals, Inc. | -3.09 Million USD | -2885.392% |
| Enlivex Therapeutics Ltd. | 106 Thousand USD | 87245.283% |
| Conduit Pharmaceuticals Inc. | -3.24 Million USD | -2748.412% |
| SeaStar Medical Holding Corporation | 8.9 Million USD | 1137.327% |
| FibroBiologics, Inc. Common Stock | -7.41 Million USD | -1145.604% |
| Altimmune, Inc. | -134.48 Million USD | 31.314% |
| Amicus Therapeutics, Inc. | 198.06 Million USD | 146.638% |
| Alpha Tau Medical Ltd. | -2.53 Million USD | -3546.822% |
| Compugen Ltd. | -12.9 Million USD | -615.856% |
| Peak Bio, Inc. | 10.34 Million USD | 993.352% |
| Zevra Therapeutics, Inc. | -283 Thousand USD | -32540.989% |
| Benitec Biopharma Inc. | -50.58 Million USD | -82.622% |
| Spyre Therapeutics, Inc. | -104.33 Million USD | 11.467% |
| NKGen Biotech, Inc. Common Stock | 19.64 Million USD | 570.216% |
| Zura Bio Limited | -99.8 Million USD | 7.446% |
| PolyPid Ltd. | 6.17 Million USD | 1597.147% |
| Aileron Therapeutics, Inc. | 74.12 Million USD | 224.628% |
| NKGen Biotech, Inc. Warrants | 19.64 Million USD | 570.216% |
| Instil Bio, Inc. | 75.35 Million USD | 222.58% |
| argenx SE | -2.02 Billion USD | 95.447% |
| Immunome, Inc. | -97.02 Million USD | 4.798% |
| Compass Therapeutics, Inc. | -22.49 Million USD | -310.642% |
| Verona Pharma plc | -220.44 Million USD | 58.096% |
| enGene Holdings Inc. Warrants | -71.74 Million USD | -28.757% |
| Shattuck Labs, Inc. | -121.42 Million USD | 23.924% |
| CervoMed Inc. | -7.79 Million USD | -1085.369% |
| LENZ Therapeutics, Inc. | -185.49 Million USD | 50.202% |
| Plus Therapeutics, Inc. | -4.37 Million USD | -2012.371% |
| Dianthus Therapeutics, Inc. | -131.73 Million USD | 29.882% |
| Moolec Science SA | 117.61 Thousand USD | 78638.634% |
| Enveric Biosciences, Inc. | -2.28 Million USD | -3937.366% |
| Inovio Pharmaceuticals, Inc. | 15.89 Million USD | 681.028% |
| AnaptysBio, Inc. | -18.15 Million USD | -408.92% |
| Design Therapeutics, Inc. | -18.15 Million USD | -408.948% |
| Leap Therapeutics, Inc. | -70.38 Million USD | -31.248% |
| NeurAxis, Inc. | 145.7 Thousand USD | 63500.137% |
| Seelos Therapeutics, Inc. | 11.23 Million USD | 922.418% |
| Lumos Pharma, Inc. | -28.49 Million USD | -224.199% |
| Achilles Therapeutics plc | -126.92 Million USD | 27.221% |
| enGene Holdings Inc. Common Stock | -71.74 Million USD | -28.757% |
| 180 Life Sciences Corp. | -655.73 Thousand USD | -13987.201% |
| Opiant Pharmaceuticals, Inc. | -20.77 Million USD | -344.665% |
| CERo Therapeutics Holdings, Inc. | 1.45 Million USD | 6435.113% |
| Nutriband Inc. | -251.65 Thousand USD | -36606.311% |
| ORIC Pharmaceuticals, Inc. | -13.17 Million USD | -601.344% |
| CG Oncology, Inc. Common stock | -7.44 Million USD | -1141.586% |
| Fractyl Health, Inc. Common Stock | 340.19 Million USD | 127.153% |
| Rani Therapeutics Holdings, Inc. | 23.73 Million USD | 489.189% |
| MoonLake Immunotherapeutics | -447.47 Million USD | 79.356% |
| Palisade Bio, Inc. | -12.06 Million USD | -665.763% |
| Tourmaline Bio, Inc. | -140.31 Million USD | 34.165% |
| Beam Therapeutics Inc. | -262.72 Million USD | 64.84% |
| Neurogene Inc. | -131.95 Million USD | 29.996% |
| Mirum Pharmaceuticals, Inc. | 21.81 Million USD | 523.423% |
| AEON Biopharma, Inc. | -4.88 Million USD | -1792.91% |
| CARGO Therapeutics, Inc. Common Stock | -377.19 Million USD | 75.51% |
| Sesen Bio, Inc. | -112.55 Million USD | 17.928% |
| Enliven Therapeutics, Inc. | -99.86 Million USD | 7.496% |
| Kiora Pharmaceuticals, Inc. | -2.34 Million USD | -3834.504% |
| Iovance Biotherapeutics, Inc. | -39.02 Million USD | -136.699% |
| Taysha Gene Therapies, Inc. | -83.28 Million USD | -10.917% |
| Athira Pharma, Inc. | -88.99 Million USD | -3.792% |
| Vaccinex, Inc. | -1.28 Million USD | -7071.894% |
| HCW Biologics Inc. | 2.85 Million USD | 3333.618% |
| XOMA Corporation | -29 Million USD | -218.531% |
| Nektar Therapeutics | 210.24 Million USD | 143.937% |
| Arvinas, Inc. | -313.8 Million USD | 70.563% |
| Tevogen Bio Holdings Inc. | 1.62 Million USD | 5791.945% |
| Merus N.V. | -192.88 Million USD | 52.109% |
| Omega Therapeutics, Inc. | 59.98 Million USD | 253.995% |
| Quince Therapeutics, Inc. | -6.93 Million USD | -1231.421% |
| Rezolute, Inc. | -68.16 Million USD | -35.509% |
| Clene Inc. | 3.34 Million USD | 2865.689% |
| Indaptus Therapeutics, Inc. | -13.18 Million USD | -600.493% |
| BeyondSpring Inc. | -13.75 Million USD | -571.567% |
| Synlogic, Inc. | -6.68 Million USD | -1281.81% |
| Allarity Therapeutics, Inc. | 1.13 Million USD | 8245.855% |
| Phio Pharmaceuticals Corp. | -8.45 Million USD | -992.537% |
| Peak Bio, Inc. | 10.34 Million USD | 993.352% |
| Werewolf Therapeutics, Inc. | -82.42 Million USD | -12.077% |
| Krystal Biotech, Inc. | -350.23 Million USD | 73.625% |
| Karyopharm Therapeutics Inc. | 124.12 Million USD | 174.42% |
| SpringWorks Therapeutics, Inc. | -168.99 Million USD | 45.34% |
| Lipella Pharmaceuticals Inc. | -3.15 Million USD | -2825.872% |
| MannKind Corporation | 143.89 Million USD | 164.194% |
| Ikena Oncology, Inc. | -109.15 Million USD | 15.374% |
| Cyclerion Therapeutics, Inc. | -7.57 Million USD | -1120.103% |
| Gyre Therapeutics, Inc. | -33.1 Million USD | -179.076% |
| Gossamer Bio, Inc. | 180.35 Million USD | 151.218% |
| CohBar, Inc. | -5.93 Million USD | -1457.548% |
| Cognition Therapeutics, Inc. | -29.74 Million USD | -210.522% |
| NRx Pharmaceuticals, Inc. | 4.56 Million USD | 2123.084% |
| Legend Biotech Corporation | -949.39 Million USD | 90.27% |
| Mural Oncology plc | -255.84 Million USD | 63.894% |
| Biora Therapeutics, Inc. | 32.21 Million USD | 386.742% |
| PaxMedica, Inc. Common Stock | -4.71 Million USD | -1860.964% |
| Disc Medicine, Inc. | -358.28 Million USD | 74.217% |
| Champions Oncology, Inc. | 4.81 Million USD | 2019.659% |
| REGENXBIO Inc. | 54.76 Million USD | 268.664% |
| Ensysce Biosciences, Inc. | -268.9 Thousand USD | -34251.653% |
| Anavex Life Sciences Corp. | -151.02 Million USD | 38.835% |
| Cellectar Biosciences, Inc. | -9.01 Million USD | -925.01% |
| Edgewise Therapeutics, Inc. | -80.68 Million USD | -14.49% |
| Vaxart, Inc. | -8.24 Million USD | -1020.908% |
| PharmaCyte Biotech, Inc. | -50.17 Million USD | -84.085% |
| Aldeyra Therapeutics, Inc. | -127.16 Million USD | 27.359% |
| Cellectis S.A. | -43.85 Million USD | -110.635% |
| Longeveron Inc. | -2.9 Million USD | -3076.547% |
| Repare Therapeutics Inc. | -107.85 Million USD | 14.356% |
| Sarepta Therapeutics, Inc. | 968.37 Million USD | 109.539% |
| Inozyme Pharma, Inc. | 12 Million USD | 869.527% |
| Revolution Medicines, Inc. | -608.2 Million USD | 84.812% |
| Nymox Pharmaceutical Corporation | -1.23 Million USD | -7410.081% |
| Third Harmonic Bio, Inc. | -265.11 Million USD | 65.157% |
| ArriVent BioPharma, Inc. Common Stock | -150.07 Million USD | 38.447% |
| AN2 Therapeutics, Inc. | -15.64 Million USD | -490.362% |
| Anixa Biosciences, Inc. | -740 Thousand USD | -12382.973% |
| Vertex Pharmaceuticals Incorporated | -9.56 Billion USD | 99.034% |
| Denali Therapeutics Inc. | -74.86 Million USD | -23.387% |
| Revelation Biosciences, Inc. | -11.99 Million USD | -670.316% |
| Veru Inc. | 4.77 Million USD | 2032.523% |
| Corvus Pharmaceuticals, Inc. | -11.24 Million USD | -721.394% |
| Cingulate Inc. | 3.08 Million USD | 3096.546% |
| Passage Bio, Inc. | 4.58 Million USD | 2114.7% |
| Context Therapeutics Inc. | -14.44 Million USD | -539.274% |
| Exicure, Inc. | 5.84 Million USD | 1679.313% |
| Day One Biopharmaceuticals, Inc. | -230.37 Million USD | 59.903% |
| Oramed Pharmaceuticals Inc. | -39.57 Million USD | -133.445% |
| Scinai Immunotherapeutics Ltd. | 15.69 Million USD | 688.707% |
| Rhythm Pharmaceuticals, Inc. | -58.82 Million USD | -57.043% |
| Nuvalent, Inc. | -335.38 Million USD | 72.457% |
| ABVC BioPharma, Inc. | 1.73 Million USD | 5426.173% |
| Carisma Therapeutics, Inc. | -74.48 Million USD | -24.022% |
| Unicycive Therapeutics, Inc. | -8.89 Million USD | -939.078% |
| OmniAb, Inc. | 9.2 Million USD | 1103.738% |
| Anew Medical, Inc. | 1.43 Million USD | 6548.604% |
| Fennec Pharmaceuticals Inc. | 16.38 Million USD | 663.883% |
| Lipocine Inc. | -4.75 Million USD | -1842.838% |
| Lexeo Therapeutics, Inc. Common Stock | -109.82 Million USD | 15.892% |
| Nautilus Biotechnology, Inc. | 15.23 Million USD | 706.487% |
| SAB Biotherapeutics, Inc. | -50.65 Million USD | -82.345% |
| G1 Therapeutics, Inc. | 24.89 Million USD | 471.099% |
| Bellerophon Therapeutics, Inc. | -6.72 Million USD | -1274.409% |
| Sage Therapeutics, Inc. | -65.82 Million USD | -40.328% |
| Ocugen, Inc. | -32.52 Million USD | -184.044% |
| Mind Medicine (MindMed) Inc. | -85.57 Million USD | -7.945% |
| Q32 Bio Inc. | -37.94 Million USD | -143.423% |
| Brainstorm Cell Therapeutics Inc. | -628 Thousand USD | -14609.236% |
| Alumis Inc. Common Stock | -13.52 Million USD | -582.785% |
| Equillium, Inc. | -22.39 Million USD | -312.531% |
| Kyverna Therapeutics, Inc. | -25.56 Million USD | -261.288% |
| Coya Therapeutics, Inc. | -32.62 Million USD | -183.123% |
| CNS Pharmaceuticals, Inc. | -247.91 Thousand USD | -37160.351% |
| Galera Therapeutics, Inc. | 134.04 Million USD | 168.914% |
| Evelo Biosciences, Inc. | 3.19 Million USD | 2988.493% |
| Comera Life Sciences Holdings, Inc. | 328.44 Thousand USD | 28224.99% |
| Dominari Holdings Inc. | 195 Thousand USD | 47471.282% |
| Edesa Biotech, Inc. | -5.26 Million USD | -1653.856% |
| vTv Therapeutics Inc. | -8.91 Million USD | -935.931% |
| Bio-Techne Corporation | 267.74 Million USD | 134.5% |
| Agios Pharmaceuticals, Inc. | -16.2 Million USD | -469.893% |
| Harmony Biosciences Holdings, Inc. | -118.09 Million USD | 21.779% |
| Prelude Therapeutics Incorporated | -8.4 Million USD | -999.298% |
| Candel Therapeutics, Inc. | -12.65 Million USD | -630.172% |
| iTeos Therapeutics, Inc. | -245.11 Million USD | 62.315% |
| Nkarta, Inc. | 57.29 Million USD | 261.214% |
| BioCardia, Inc. | 212 Thousand USD | 43672.642% |
| Iterum Therapeutics plc | 13.43 Million USD | 787.409% |